NF-κB Inhibitor Parthenolide Promotes Renal Tubules Albumin Uptake in Type 2 Diabetic Nephropathy

Area of Science:

• Nephrology
• Endocrinology
• Molecular Biology

Background:

• Diabetic nephropathy is characterized by increased albuminuria, linked to impaired tubular reabsorption.
• The precise mechanisms underlying reduced tubular albumin uptake in early diabetic nephropathy remain unclear.
• Inflammation and disrupted insulin signaling are implicated in diabetic kidney disease progression.

Purpose of the Study:

• To investigate whether inhibiting inflammation and modulating insulin signaling can enhance renal tubular albumin uptake.
• To explore the therapeutic potential of parthenolide (PTN), a nuclear factor kappa-B (NF-κB) inhibitor, in a mouse model of type 2 diabetic nephropathy.

Main Methods:

• Utilized 8-week-old male db/db mice (type 2 diabetic nephropathy model) treated with PTN or saline.
• Age-matched db/m mice served as controls.
• Assessed insulin resistance (HOMA-IR), albuminuria, renal histopathology (PAS staining), NF-κB p65, p-AKT, amnionless, and cubilin expression via immunohistochemistry and Western blot.
• Evaluated albumin uptake in renal tubules using immunofluorescence and in human kidney cells (HKC) exposed to insulin, TNF-α, and PTN.

Main Results:

• PTN treatment in db/db mice showed a trend towards decreased HOMA-IR and albuminuria, alleviated glomerular hypertrophy, and reduced mesangial matrix.
• PTN significantly reduced renal NF-κB p65 expression and ameliorated the decline in p-AKT levels.
• In db/db mice and HKC cells, PTN increased cubilin expression and enhanced albumin uptake, counteracting TNF-α-induced inflammation and insulin signaling impairment.

Conclusions:

• Inflammation exacerbates insulin signaling damage, leading to reduced amnionless-cubilin expression and impaired albumin uptake in diabetic nephropathy.
• Parthenolide (PTN) mitigates inflammation and restores insulin signaling pathways, thereby promoting cubilin expression and improving renal tubular albumin uptake.
• These findings highlight the role of inflammation in reduced albumin uptake and suggest PTN as a potential therapeutic strategy for diabetic kidney disease.